In a number of studies, the expression of different iron-regulated genes such as TfR [76], FTL [77,78], and IRP2 [79] in tumor cells was correlated with a poor prognosis and a higher tumor grade, leading to increased chemoresistance in cancer patients. This evidence concerns the gene IREB2 and neoplasm.